Can-Fite Reports First Quarter 2020 Financial Results & Provides Clinical Update
PETACH TIKVA, Israel–(BUSINESS WIRE)–Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today announced financial results for the three months ended March 31, 2020. Clinical Developments and Corporate Highlights Include: Namodenoson Showed Significant Efficacy in Phase II NASH Study…